Last $40.09 USD
Change Today +0.19 / 0.48%
Volume 349.0K
AGIO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lewis Clayton Cantley Ph.D.

Co-Founder, Director, Member of Scientific Advisory Board and Member of Nominating & Corporate Governance Committee, Agios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 90 board members in 5 different organizations across 4 different industries.

See Board Relationships
65--

Background*

Dr. Lewis Clayton Cantley, Ph.D Co-Founded Agios Pharmaceuticals Inc. Dr. Cantley is a Professor of Cell Biology and Systems Biology at Harvard Medical School and Chief of the Division of Signal Transduction at Beth Israel Deaconess Medical Center. He serves as Co-Editor-In-Chief for the AACRs newest journal, Cancer Discovery. Dr. Cantley joined the Department of Biochemistry and Molecular Biology at Harvard in 1978 as its Assistant Professor. Dr. Cantley focused on ...

Read Full Background

Corporate Headquarters*

38 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-649-8600
Fax: --

Board Members Memberships*

2007-Present
Co-Founder, Director, Member of Scientific Advisory Board and Member of Nominating & Corporate Governance Committee
2012-Present
Director

Education*

PhD 1975
Cornell University
Post-Doctoral Training 1978
Harvard University
BS 1971
West Virginia Wesleyan College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGIO:US $40.09 USD +0.19

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGIOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.